Pharma, bio and medical device companies which want to export their products to new
markets.
R&D companies with late stage biotech development products and limited international
business development capacity.
Technology licensing organisations (TLOs), research institutions, hospitals and universities
searching for opportunities to out-license their IP or looking for partners to assist with
the ongoing development of their early stage assets.
Development companies which want access to the above mentioned companies and
institutions.
Companies in developing markets which want to develop their product portfolio and
expand their business to the global market.